Thermo Fisher Scientific Income Statement
TMO / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Thermo Fisher Scientific reported $44.6B in revenue and $6.7B in net income for FY2025. Revenue has grown at a 10.1% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.6B | $42.9B | $39.2B | $32.2B | $25.5B | $32.2B | $25.5B | $24.4B | $4.8B | $18.3B | $17.0B | $16.9B | $13.1B | $12.5B | $11.6B |
| Cost of Revenue | - | - | - | - | - | - | - | - | $9.0B | $8.2B | $7.6B | $7.9B | $6.3B | $6.1B | $5.7B |
| Gross Profit | - | - | - | - | - | - | - | $2.6B | $2.2B | $2.0B | $1.8B | $1.6B | $1.3B | $1.3B | $1.1B |
| SG&A Expense | $8.7B | $8.6B | $8.0B | $6.9B | $6.1B | $6.9B | $6.1B | $6.1B | $5.5B | $5.0B | $4.6B | $4.9B | $3.4B | $3.4B | $3.1B |
| R&D Expense | $1.4B | $1.4B | $1.4B | $1.2B | $1.0B | $1.2B | $1.0B | $967.0M | $887.0M | $754.0M | $692.0M | $691.1M | $395.5M | $376.4M | $340.2M |
| Operating Income | $7.7B | $7.3B | $10.0B | $7.8B | $4.6B | $7.8B | $4.6B | $3.8B | $3.0B | $2.5B | $2.3B | $2.5B | $1.6B | $1.5B | $1.3B |
| Interest Expense | - | - | $536.0M | $553.0M | $676.0M | $553.0M | $676.0M | $667.0M | $592.0M | $469.0M | $415.0M | $479.9M | $262.1M | $241.6M | $175.3M |
| Income Tax | $547.0M | $657.0M | $1.1B | $850.0M | $374.0M | $850.0M | $374.0M | $324.0M | $201.0M | -$1.0M | -$44.0M | $191.7M | $40.4M | $11.0M | $109.4M |
| Net Income | $6.7B | $6.3B | $7.7B | $6.4B | $3.7B | $6.4B | $3.7B | - | - | - | - | - | $336.2M | $277.3M | $1.3B |
| EPS (Basic) | $15.52 | $17.75 | $19.62 | $16.09 | $9.24 | $7.31 | $5.64 | $5.12 | $4.96 | $4.76 | $3.53 | $3.24 | $3.49 | $2.57 | $2.06 |
| EPS (Diluted) | $15.45 | $17.63 | $19.46 | $15.96 | $9.17 | $7.24 | $5.59 | $5.09 | $4.92 | $4.71 | $3.48 | $3.21 | $3.46 | $2.53 | $2.01 |
| Shares Outstanding | 388.0M | 394.0M | 397.0M | 399.0M | 403.0M | 406.0M | 398.0M | 397.0M | 402.0M | 402.3M | 365.8M | 366.6M | 384.8M | 409.4M | 422.8M |
| Gross Margin | - | - | - | - | - | - | - | 10.6% | 46.0% | 10.7% | 10.7% | 9.6% | 10.2% | 10.3% | 9.7% |
| Operating Margin | 17.4% | 17.1% | 25.6% | 24.2% | 18.0% | 24.2% | 18.0% | 15.5% | 62.1% | 13.5% | 13.8% | 14.8% | 12.3% | 11.8% | 10.8% |
| Profit Margin | 15.0% | 14.8% | 19.7% | 19.8% | 14.5% | 19.8% | 14.5% | - | - | - | - | - | 2.6% | 2.2% | 11.5% |